SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jonas Grumby who wrote (668)6/30/1998 2:21:00 PM
From: Peter Singleton  Read Replies (2) of 1510
 
Folks,

I agree with you guys that the news should be great later this week, and
there's a chance for institutional buying plus retail, especially if
there's a popular press article like the WSJ article on Sustiva today.

But, what do you think are the chances of a sell-off on the news? The
expectation that Valentine will present significant results has gotten a
lot of airplay, and the stock has run from 11 to 15 (with a spike to
19).

I've bought IMNR + IMNR calls + AGPH calls, so obviously I think the
news will be material, and have long-lasting implications for the value
of both stocks ... but I recognize there's a chance that the market has
already absorbed the news. My best guess is that it hasn't, and there
will be some run in the stock(s), but that's just a guess.

What do you guys think?

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News